newsfilter
← Latest News
PR Newswire·

Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results

Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of...